Browsing Tag
Serum Institute of India
7 posts
Is NB.1.8.1 already in India? Inside the ICMR’s variant surveillance in May 2025
NB.1.8.1 variant not yet detected in India, says ICMR; airports and labs intensify COVID surveillance as Hong Kong battles a deadly surge.
May 28, 2025
Wockhardt UK and Serum Life Sciences UK join forces to deliver 150 million vaccine doses annually from new fill-finish facility
Find out how Wockhardt and Serum Life Sciences UK are reshaping global vaccine supply with a new high-capacity facility—read more now.
March 20, 2022
Biocon to sell 15% stake in Biocon Biologics to Serum Institute of India
Biocon has agreed to divest a stake of around 15% in its subsidiary — Biocon Biologics Limited (BBL)…
September 16, 2021
Magma Fincorp shareholders approve acquisition by Rising Sun Holdings
Magma Fincorp said that its shareholders have approved Rising Sun Holdings’ (RSHPL) acquisition of a controlling stake in…
March 10, 2021
Rising Sun Holdings to acquire controlling stake in Magma Fincorp
Rising Sun Holdings (RSHPL), a company controlled by Serum Institute of India CEO Adar Poonawalla, has agreed to…
February 11, 2021
India grants emergency approval to Covishield and Covaxin vaccines for Covid-19
In a significant development in the battle against Covid-19, the Drugs Controller General of India (DCGI) has granted…
January 3, 2021
India’s DCGI grants emergency approval to Covishield and Covaxin vaccines
In a major step forward in India’s fight against the Covid-19 pandemic, the Drugs Controller General of India…
January 3, 2021